作者: AS Berghoff , A Ilhan-Mutlu , M Preusser , A Woehrer , JA Hainfellner
DOI: 10.1007/S00066-014-0639-8
关键词: Survival analysis 、 Carcinoma 、 Oncology 、 Alpha (ethology) 、 Lung cancer 、 Primary tumor 、 Immunohistochemistry 、 Internal medicine 、 Medicine 、 Radiation therapy 、 Proliferation index
摘要: Survival upon diagnosis of brain metastases (BM) in patients with non-small cell lung cancer (NSCLC) is highly variable and established prognostic scores do not include tissue-based parameters. Patients who underwent neurosurgical resection as first-line therapy for newly diagnosed NSCLC BM were included. Microvascular density (MVD), Ki67 tumor proliferation index hypoxia-inducible factor 1 alpha (HIF-1 alpha) determined by immunohistochemistry. NSCLC BM specimens from 230 (151 male, 79 female; median age 56 years; 199 nonsquamous histology) 53/230 (23.0 %) matched primary samples available. Adjuvant whole-brain radiation (WBRT) was given to 153/230 (66.5 %) after resection. MVD HIF-1 indices significantly higher than tumors. In treated adjuvant WBRT, low expression associated favorable overall survival (OS), while among did correlate OS. Low diagnosis-specific graded assessment score (DS-GPA), index, high MVD, administration WBRT independently Incorporation parameters into the commonly used DS-GPA allowed refined discrimination subgroups. have promising value should be validated further studies.